ViralkumarKBhanderiMD

Oncology • Tallahassee, FL

Breast Cancer, Gastrointestinal Cancer, Hematologic Oncology, Thoracic Cancer

Physician

Join to view full profile

Dr. Bhanderi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bhanderi's full profile

Already have an account?

Office
Florida Cancer Specialists
2351 Phillips road
Tallahassee, FL 32308
Phone+1 850-877-8166

Fax+1 850-877-0431
Is this information wrong?

Summary

Dr. Viralkumar Bhanderi is an oncologist in Tallahassee, FL and is affiliated with multiple hospitals in the area, including Capital Regional Medical Center, UF Health Shands Hospital, and Tallahassee Memorial HealthCare. He received his medical degree from Louisiana State University School of Medicine in Shreveport and has been in practice 15 years. He specializes in oncology.

Education & Training

University of FloridaFellowship, Hematology and Medical Oncology, 2006 - 2008
University of FloridaResidency, Internal Medicine, 2002 - 2006
LSU School of Medicine in ShreveportClass of 2002

Certifications & Licensure

FL State Medical License 2008 - 2026
GA State Medical License 2005 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014

Clinical Trials

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors Start of enrollment: 2017 Sep 27
Recruiting
Phase 2
Study of Tazemetostat Versus Placebo When Given in Combination With Lenalidomide and Rituximab in Participants With Relapsed/Refractory Follicular Lymphoma Start of enrollment: 2020 Jun 11
Recruiting
Phase 3
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer Start of enrollment: 2020 May 28
Active, not recruiting
Phase 2
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer Start of enrollment: 2020 Aug 12
Active, not recruiting
Phase 3
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer Start of enrollment: 2020 Jul 07
Active, not recruiting
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

23 citations
Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)
David R. Spigel, Robert M. Jotte, John Nemunaitis, Merrill Kingman Shum, Jeffrey A. Schneider, Jerome H. Goldschmidt, Jennifer L. Eisenstein, David Berz, Lasika Senevi...> ;Journal of Thoracic Oncology. 2021 Feb 1
23 citations
Association of diurnal blood pressure pattern with risk of hospitalization or death in men with heart failure.
Jaekyu Shin, Sharoen E. Kline, Mariellen J. Moore, Yan Gong, Viralkumar Bhanderi, Carsten Schmalfuss, Julie A. Johnson, Richard S. Schofield> ;Journal of Cardiac Failure. 2007 Oct 1

Hospital Affiliations

HCA Florida Capital HospitalTallahassee, Florida
UF Health Shands HospitalGainesville, Florida
Tallahassee Memorial HealthCareTallahassee, Florida